Literature DB >> 9804039

The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.

A Waki1, H Kato, R Yano, N Sadato, A Yokoyama, Y Ishii, Y Yonekura, Y Fujibayashi.   

Abstract

Glucose transporter (GLUT) expression and hexokinase activity are thought to be related to high [18F]-fluorodeoxyglucose (FDG) uptake in tumor cells, but their relative importance is still unknown. To determine which is the predominant factor in FDG uptake in tumor cells, cultured tumor cell lines and a normal cell line were studied in vitro with respect to 2-deoxyglucose (DG) uptake, hexokinase activity, and the initial uptake rate of 3-O-methylglucose (3-O-MG) transport, which is generally accepted as indicating the amount of GLUT expressed on the plasma membrane. In 16 types of tumor cells and one fibroblast cell line, DG uptake was assessed for 60 min, the initial uptake rate of 3-O-MG transport was measured for 1 min, and total hexokinase activity, including that in the mitochondrial fraction, was determined. Across all 16 tumor cell lines, there was a significant correlation between DG uptake and 3-O-MG transport (p = 0.0012, F test), but not between DG uptake and hexokinase activity. Hexokinase activity of the tumor cells was comparable to that of the human fibroblast cells in the exponential growth phase. Most tumor cells showed higher DG uptake and 3-O-MG transport than the human fibroblast cells. The results suggest that DG uptake of cultured tumor cells is governed by GLUT expression, which may be a distinct characteristic of the neoplastic process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804039     DOI: 10.1016/s0969-8051(98)00038-9

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  18 in total

1.  Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro.

Authors:  M W Pedersen; S Holm; E L Lund; L Højgaard; P E Kristjansen
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.

Authors:  Xiao-Feng Li; Yuanyuan Ma; Xiaorong Sun; John L Humm; C Clifton Ling; Joseph A O'Donoghue
Journal:  J Nucl Med       Date:  2010-04       Impact factor: 10.057

Review 3.  Breast Cancer Metabolism.

Authors:  Jessica Tan; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

4.  An evaluation of 2-deoxy-2-[18F]fluoro-D-glucose and 3'-deoxy-3'-[18F]-fluorothymidine uptake in human tumor xenograft models.

Authors:  Heather Keen; Bernd Pichler; Damaris Kukuk; Olivier Duchamp; Olivier Raguin; Aoife Shannon; Nichola Whalley; Vivien Jacobs; Juliana Bales; Neill Gingles; Sally-Ann Ricketts; Stephen R Wedge
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

5.  The Structural Basis of Action of Vanadyl (VO2+) Chelates in Cells.

Authors:  Marvin W Makinen; Marzieh Salehitazangi
Journal:  Coord Chem Rev       Date:  2014-11-01       Impact factor: 22.315

6.  Assessment of cell proliferation in renal cell carcinoma using dual-phase 18F-fluorodeoxyglucose PET/CT.

Authors:  Rei Onishi; Masanori Noguchi; Hayato Kaida; Fukuko Moriya; Katsuaki Chikui; Seiji Kurata; Akihiko Kawahara; Masayoshi Kage; Masatoshi Ishibashi; Kei Matsuoka
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

7.  Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.

Authors:  Toshio Sasajima; Tadashi Miyagawa; Takamitsu Oku; Juri G Gelovani; Ronald Finn; Ronald Blasberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-13       Impact factor: 9.236

8.  2-deoxy-2-[F-18]fluoro-D-glucose accumulation in ovarian carcinoma cell lines.

Authors:  A M Lutz; P Ray; J K Willmann; Charles Drescher; S S Gambhir
Journal:  Mol Imaging Biol       Date:  2007 Sep-Oct       Impact factor: 3.488

9.  The vanadyl chelate bis(acetylacetonato)oxovanadium(IV) increases the fractional uptake of 2-(fluorine-18)-2-deoxy-D-glucose by cultured human breast carcinoma cells.

Authors:  Marvin W Makinen; Ravinder Bamba; Lynda Ikejimba; Christian Wietholt; Chin-Tu Chen; Suzanne D Conzen
Journal:  Dalton Trans       Date:  2013-09-07       Impact factor: 4.390

10.  The Heterogeneity of Breast Cancer Metabolism.

Authors:  Jessica Tan; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.